Suppr超能文献

非酒精性脂肪性肝病组织学评分系统的设计与验证

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

作者信息

Kleiner David E, Brunt Elizabeth M, Van Natta Mark, Behling Cynthia, Contos Melissa J, Cummings Oscar W, Ferrell Linda D, Liu Yao-Chang, Torbenson Michael S, Unalp-Arida Aynur, Yeh Matthew, McCullough Arthur J, Sanyal Arun J

机构信息

Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA.

出版信息

Hepatology. 2005 Jun;41(6):1313-21. doi: 10.1002/hep.20701.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis in the absence of a history of significant alcohol use or other known liver disease. Nonalcoholic steatohepatitis (NASH) is the progressive form of NAFLD. The Pathology Committee of the NASH Clinical Research Network designed and validated a histological feature scoring system that addresses the full spectrum of lesions of NAFLD and proposed a NAFLD activity score (NAS) for use in clinical trials. The scoring system comprised 14 histological features, 4 of which were evaluated semi-quantitatively: steatosis (0-3), lobular inflammation (0-2), hepatocellular ballooning (0-2), and fibrosis (0-4). Another nine features were recorded as present or absent. An anonymized study set of 50 cases (32 from adult hepatology services, 18 from pediatric hepatology services) was assembled, coded, and circulated. For the validation study, agreement on scoring and a diagnostic categorization ("NASH," "borderline," or "not NASH") were evaluated by using weighted kappa statistics. Inter-rater agreement on adult cases was: 0.84 for fibrosis, 0.79 for steatosis, 0.56 for injury, and 0.45 for lobular inflammation. Agreement on diagnostic category was 0.61. Using multiple logistic regression, five features were independently associated with the diagnosis of NASH in adult biopsies: steatosis (P = .009), hepatocellular ballooning (P = .0001), lobular inflammation (P = .0001), fibrosis (P = .0001), and the absence of lipogranulomas (P = .001). The proposed NAS is the unweighted sum of steatosis, lobular inflammation, and hepatocellular ballooning scores. In conclusion, we present a strong scoring system and NAS for NAFLD and NASH with reasonable inter-rater reproducibility that should be useful for studies of both adults and children with any degree of NAFLD. NAS of > or =5 correlated with a diagnosis of NASH, and biopsies with scores of less than 3 were diagnosed as "not NASH."

摘要

非酒精性脂肪性肝病(NAFLD)的特征是在没有大量饮酒史或其他已知肝脏疾病的情况下出现肝脂肪变性。非酒精性脂肪性肝炎(NASH)是NAFLD的进展形式。NASH临床研究网络病理委员会设计并验证了一种组织学特征评分系统,该系统涵盖了NAFLD的全谱病变,并提出了用于临床试验的NAFLD活动评分(NAS)。该评分系统包括14个组织学特征,其中4个进行半定量评估:脂肪变性(0 - 3)、小叶炎症(0 - 2)、肝细胞气球样变(0 - 2)和纤维化(0 - 4)。另外9个特征记录为存在或不存在。收集了一组50例匿名研究病例(32例来自成人肝病科,18例来自儿科肝病科),进行编码并分发。对于验证研究,使用加权kappa统计量评估评分和诊断分类(“NASH”、“临界”或“非NASH”)的一致性。成人病例的评分者间一致性为:纤维化0.84,脂肪变性0.79,损伤0.56,小叶炎症0.45。诊断分类的一致性为0.6l。使用多元逻辑回归分析,成人活检中与NASH诊断独立相关的有5个特征:脂肪变性(P = 0.009)、肝细胞气球样变(P = 0.0001)、小叶炎症(P = 0.0001)、纤维化(P = 0.0001)以及无脂性肉芽肿(P = 0.001)。提议的NAS是脂肪变性、小叶炎症和肝细胞气球样变评分的未加权总和。总之,我们提出了一个强大的NAFLD和NASH评分系统及NAS,具有合理的评分者间可重复性,这对于研究任何程度NAFLD的成人和儿童都应是有用的。NAS≥5与NASH诊断相关,评分小于3的活检诊断为“非NASH”。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验